Filing search / Underwriting / Soleno Therapeutics, Inc.

SC 13G

EX-1

Avoro Capital Advisors LLC

14 Nov 24

SOLENO THERAPEUTICS / Avoro Capital Advisors ownership change

9:36am

8-K

EX-1.1

SLNO Soleno Therapeutics, Inc.

19 Jul 24

Entry into a Material Definitive Agreement

5:04pm

8-K

EX-1.1

SLNO Soleno Therapeutics, Inc.

7 May 24

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock

5:28pm

8-K

EX-1.1

SLNO Soleno Therapeutics, Inc.

29 Sep 23

Entry into a Material Definitive Agreement

4:55pm

8-K

EX-1.2

SLNO Soleno Therapeutics, Inc.

29 Sep 23

Entry into a Material Definitive Agreement

4:55pm

8-K

EX-1.1

su1k b3exczabi

30 Mar 22

Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering

5:24pm

8-K

EX-1.1

y4g 0tgx6301bv6rq

16 Jul 21

Entry into a Material Definitive Agreement

4:14pm

8-K

EX-1.1

ohj29lu9 pie808q0

26 Jun 20

Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock

4:31pm

8-K

EX-1.1

zhmjz4

25 Oct 19

Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock

4:03pm

SC 13D

EX-1

1yxgjo4pcdt0

27 Dec 18

Soleno Therapeutics Inc

4:20pm

8-K

EX-1.1

paq 2r34y

6 Jul 16

Capnia Announces Private Placement of Up to $13.8 Million of Convertible Preferred Stock

12:00am

8-K

EX-1.1

4cs4ph5

15 Oct 15

Capnia Announces Private Placement of Up to $10 Million of Convertible Preferred Stock and Warrants

12:00am